
Diffuse Bio
Diffuse Bio is a YC Winter 2023 (W23) company. Based in San Carlos, CA, USA. Team of 10.
About Diffuse Bio
Summary
Diffuse Bio develops generative AI tools for designing novel proteins, targeting researchers and drug developers who need precise control over protein structure and sequence. The platform produces biologically validated outputs at scale, replacing slow, trial-and-error wet-lab iteration with AI-driven generation. The team's work spans both diffusion-based sequence design and experimental confirmation of AI-created proteins.
From the Y Combinator listing
Generative AI for protein design
Diffuse is building generative AI for protein design. Our mission is to build AI systems that engineer new and useful proteins with unprecedented control and accuracy. Our team has been behind breakthroughs in AI protein design for the past 7 years, including the first experimental validation of AI-generated proteins and diffusion models for protein structure and sequence.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Carlos, CA, USA
- 10
- Active
- Early
Founders (1)
- Namrata Anand
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works